Poster (15W203)

IBD and Metabolic Bone disease in Beaumont hospital

Author(s)

Ashraf Monged, Conan Reilly, Jun Chin Liong, Dr Aobhlinn O'Toole

Department(s)/Institutions

Beaumont Hospital, Gastroenterology Department

Introduction

Patients with Inflammatory Bowel Disease (IBD) are at an increased risk of osteoporosis.The BSG guidelines recommend measuring bone mineral density (BMD) with Dualenergy X-ray absorptiometry (DEXA) in all patients under the age of 65 years who are exposed to corticosteroids for more than 3 months(1).

Contributing factors include chronic inflammation, corticosteroid treatment, extensive small bowel disease or resection, age, smoking, low physical activity and nutritional deficiencies.(2)

Aims/Background

The aim of this study is to present the prevalence of osteoporosis and osteopenia among IBD patient’s in Beaumont hospital.

Method

A list of Beaumont Hospital Gastroenterology patients who had DEXA scans performed in the past 9 months (January- September 2015) was generated. Patients with a diagnosis of IBD from colonoscopy reports on ENDORAAD software were selected. Patient age, sex, diagnosis and dexa results were collected and analysed.

Results

Ulcerative colitis

DEXA Normal Osteopenic Osteoporosis Total
5 12 1 18
Gender M/F 1M/4F 6M/6F 1M/0
Age below 50/above 50 4(F)/ 1(M) 8(5M,3F)/4(1M, 3F) 0/1(M)

Crohn’s disease

DEXA Normal Osteopenic Osteoporosis Total
9 9 5 24
Gender M/F 4M/5F 7M/2F 2M/3F
Age below 50/above 50 8(3M, 5F) /1(M) 6(2M,4F) /3(3F) 1(1F)/4(2M, 2F)

Osteoporosis is more common in patient s with ulcerative colitis, rather than with Crohn’s disease. The majority of patients diagnosed with osteoporosis are over the age of 50.

Conclusions

More than 50% of patients had abnormal DEXAs and we need to strive to identify risk factors.

References

1. NR Lewis & BB Scott (2007), 1. Guidelines for Osteoporosis in Inflammatory Bowel Disease and Coeliac Disease.

2. Reinshagen M. Ostoeporosis in inflammatory bowel disease,. Journal of Crohn’s and Colitis 2008;2:202-7